Background: According to the theory of traditional Chinese medicine (TCM), the spleen and stomach are the basis of acquired nature and the source of qi and blood biochemistry. After surgery and chemotherapy, patients with colorectal cancer often develop spleen and stomach qi deficiency syndrome, leading to decreased immune function. Buzhong Yiqi decoction, a classic TCM prescription, has the effect of tonifying middle-jiao and invigorating qi, boosting Yang, and suppressing immune-related inflammation. Moreover, it is widely used in the treatment of spleen and stomach qi deficiency syndrome.

Aim: To investigate the effect of Buzhong Yiqi decoction on spleen and stomach qi deficiency in patients with colorectal cancer.

Methods: One hundred patients with colorectal cancer who underwent preoperative chemotherapy and laparoscopy at The First TCM Hospital of Changde from January 2022 to October 2023 were retrospectively analyzed. The patients were divided equally into control and observation groups. Both groups underwent conventional rehabilitation surgery, and the observation group was supplemented with Buzhong Yiqi decoction. SPSS 26.0 was used for statistical analyses. The test was used for univariate analysis; independent sample -tests were used in all cases.

Results: No significant differences were observed preoperatively in the general characteristics of the two groups. Fourteen days post-surgery, the abdominal distension, emaciation, loose stool, loss of appetite, and vomiting scores were significantly lower in the observation group than in the control group ( < 0.05). Immune function and interleukin (IL)-10 levels in the observation group were significantly higher than those of the control group, whereas IL-6, tumor necrosis factor-α, and C-reactive protein levels, tumor biological indexes, and adverse reactions in the observation group were significantly lower than those of the control group ( < 0.05). One month after surgery, the patients' quality of life in the observation group was significantly higher than that of the patients in the control group ( < 0.05).

Conclusion: Buzhong Yiqi decoction can regulate inflammatory responses and metabolic processes by enhancing immune function, thereby promoting overall immune nutrition and restoring the body's balance.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11287697PMC
http://dx.doi.org/10.4240/wjgs.v16.i7.2183DOI Listing

Publication Analysis

Top Keywords

buzhong yiqi
20
yiqi decoction
20
spleen stomach
20
observation group
20
stomach deficiency
16
control group
16
colorectal cancer
12
patients colorectal
12
immune function
12
group
9

Similar Publications

The prevalence of cardiovascular diseases in China has shown a rising trend. With the patient number of about 8.9 million, heart failure has brought a heavy burden to public health and wellness.

View Article and Find Full Text PDF

This was an original article, and mainly evaluated the impacts of Buzhong Yiqi decoction and biofeedback electrical stimulation on pelvic floor muscle strength and the quality of life in patients with postpartum stress urinary incontinence (PSUI). PSUI patients (total = 256) were randomly selected into a control group and study group. The control group adopted pelvic floor muscle rehabilitation training only while the study group added Buzhong Yiqi decoction and biofeedback electrical stimulation.

View Article and Find Full Text PDF

To investigate the effect of Buzhong Yiqi Decoction on regulatory T cells(Treg) in experimental rats with autoimmune thyroiditis(EAT) through the transforming growth factor-β(TGF-β)/Smad signaling pathway. Female SD rats were immunized with iodine-rich drinking water combined with Freund's adjuvant and porcine thyroglobulin(pTG) to establish the EAT model of rats, and the levels of serum thyroperoxidase antibody(TPOAb) and thyroglobulin antibody(TGAb) were detected. Pathological sections by hematoxylin-eosin(HE) staining were observed.

View Article and Find Full Text PDF
Article Synopsis
  • The study aims to evaluate the effectiveness of the Buzhong Yiqi prescription in treating cancer-related fatigue (CRF) through meta-analysis and network pharmacology methods.
  • It focuses on randomized controlled trials (RCTs) involving various cancer patients and compares the Buzhong Yiqi treatment with conventional options, ensuring comprehensive data collection from multiple databases.
  • The evaluation of treatment efficacy was based on established quality-of-life measures and involved identifying the active ingredients in Buzhong Yiqi to understand its therapeutic mechanisms.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!